Detection of Iturin A from Bacillus atrophaeus by HPLC and Mass Spectrometry
Analysis and Evaluation of its Antifungal Activity

Solmaz   Moghtadi   Pisheh; Mahboobeh      Madani; Pegah      Shakib

doi:10.2174/1574885517666220601104811

Abstract

Background: Bacillus species create several kinds of metabolites, which contain cyclic lipopeptide-type antibiotics, consisting of three major families: fengycin, surfactin, and iturin. Iturin demonstrates powerful biocontrol characteristics and can restrain the growth of a diversity of plant fungal pathogens.

Objective: The current study investigates the identification of iturin A from Bacillus atrophaeus using HPLC and Mass spectrometry analysis and evaluate its antifungal effects.

Materials and Methods: In this study, the lipopeptide antibiotics were isolated by HPLC and characterized by MS. Then, the lipopeptides were examined for their ability to antagonize the growth of different pathogenic fungi. Antifungal performance of the lipopeptides was determined against Fusarium oxysporum, Aspergillus niger, Penicillium chrysogenum, and Mucor hiemalis according to well diffusion and percentage of growth inhibition.

Results: Bacillus atrophaeus HNSQJYH170, isolated from Isfahan soil, offered strong fungicidal activity by producing cyclic lipopeptide-type antibiotics. Inhibition zones were 17.55, 17, 18.50, and 20.99 mm, and the percentages of growth inhibition were 78.54, 62.55, 83.11, and 84/95 for Fusarium oxysporum, Penicillium chrysogenum, Mucor hiemalis and Aspergillus niger, respectively. The spectrum represented the iturins family in retention times of 32.423–33.893 min. MS demonstrated molecular ion peaks (M+H) + for iturin at m/z 1029.55, 1043.60, 1051.55, 1065.60, 1079.60 and 1093.65. The inhibition rate against all fungi on the seventh day of incubation was higher than 80%. Among them, Aspergillus niger was the most sensitive fungal species with an average of 84.95% inhibition.

Conclusion: According to the results, Bacillus atrophaeus HNSQJYH170 could operate as a biocontrol agent against a wide spectrum of pathogenic fungi.

Keywords: Bacillus atrophaeus, cyclic lipopeptides, HPLC, Iturin A, LC-MS, mass spectrometry analysis.

« Previous Next »

[1]
Sella SR, Vandenberghe LP, Soccol CR. Bacillus atrophaeus: Main characteristics and biotechnological applications - a review. Crit Rev Biotechnol  2015; 35(4): 533-45.
 [http://dx.doi.org/10.3109/07388551.2014.922915] [PMID: 24963702]

[2]
Jang H, Nguyen M-C, Noh S, et al. UV laser sterilization of Bacillus atrophaeus spores on ceramic tiles. 2022; 48(1): 1446-50.
 [http://dx.doi.org/10.1016/j.ceramint.2021.09.221]

[3]
Sella SR, Vandenberghe LP, Soccol CR. Life cycle and spore resistance of spore-forming Bacillus atrophaeus. Microbiol Res  2014; 169(12): 931-9.
 [http://dx.doi.org/10.1016/j.micres.2014.05.001] [PMID: 24880805]

[4]
Yousfi H, Ranque S, Rolain J-M, Bittar F. In vitro polymyxin activity against clinical multidrug-resistant fungi. Antimicrob Resist Infect Control  2019; 8(1): 66.
 [http://dx.doi.org/10.1186/s13756-019-0521-7] [PMID: 31044071]

[5]
Falanga A, Nigro E, De Biasi MG, et al. Cyclic peptides as novel therapeutic microbicides: Engineering of human defensin mimetics. Molecules  2017; 22(7): 1217.
 [http://dx.doi.org/10.3390/molecules22071217] [PMID: 28726740]

[6]
Zhang X, Li B, Wang Y, et al. Lipopeptides, a novel protein, and volatile compounds contribute to the antifungal activity of the biocontrol agent Bacillus atrophaeus CAB-1. Appl Microbiol Biotechnol  2013; 97(21): 9525-34.
 [http://dx.doi.org/10.1007/s00253-013-5198-x] [PMID: 24013222]

[7]
Lee DW, Kim BS. Antimicrobial cyclic peptides for plant disease control. Plant Pathol J  2015; 31(1): 1-11.
 [http://dx.doi.org/10.5423/PPJ.RW.08.2014.0074] [PMID: 25774105]

[8]
Zhao H, Shao D, Jiang C, et al. Biological activity of lipopeptides from Bacillus. Appl Microbiol Biotechnol  2017; 101(15): 5951-60.
 [http://dx.doi.org/10.1007/s00253-017-8396-0] [PMID: 28685194]

[9]
Zeriouh H, Romero D, García-Gutiérrez L, Cazorla FM, de Vicente A, Pérez-García A. The iturin-like lipopeptides are essential components in the biological control arsenal of Bacillus subtilis against bacterial diseases of cucurbits. Mol Plant Microbe Interact  2011; 24(12): 1540-52.
 [http://dx.doi.org/10.1094/MPMI-06-11-0162] [PMID: 22066902]

[10]
Son S, Ko S-K, Jang M, et al. New cyclic lipopeptides of the iturin class produced by saltern-derived Bacillus sp. KCB14S006. Mar Drugs  2016; 14(4): 72.
 [http://dx.doi.org/10.3390/md14040072] [PMID: 27049393]

[11]
Rodríguez M, Marín A, Torres M, Béjar V, Campos M. Aphicidal activity of surfactants produced by Bacillus atrophaeus L193. Front Microbiol  2018; 3: 3114.

[12]
Penha RO, Vandenberghe LPS, Faulds C, Soccol VT, Soccol CR. Bacillus lipopeptides as powerful pest control agents for a more sustainable and healthy agriculture: Recent studies and innovations. Planta  2020; 251(3): 70.
 [http://dx.doi.org/10.1007/s00425-020-03357-7] [PMID: 32086615]

[13]
Gong A-D, Li H-P, Yuan Q-S, et al. Antagonistic mechanism of iturin A and plipastatin A from Bacillus amyloliquefaciens S76-3 from wheat spikes against Fusarium graminearum. PLoS One  2015; 10(2): e0116871.
 [http://dx.doi.org/10.1371/journal.pone.0116871] [PMID: 25689464]

[14]
Zhao H, Xu X, Lei S, et al. Iturin A-like lipopeptides from Bacillus subtilis trigger apoptosis, paraptosis, and autophagy in Caco-2 cells. J Cell Physiol  2019; 234(5): 6414-27.
 [http://dx.doi.org/10.1002/jcp.27377] [PMID: 30238995]

[15]
Zhao H, Zhao X, Lei S, et al. Effect of cell culture models on the evaluation of anticancer activity and mechanism analysis of the potential bioactive compound, iturin A, produced by Bacillus subtilis. Food Funct  2019; 10(3): 1478-89.
 [http://dx.doi.org/10.1039/C8FO02433B] [PMID: 30778489]

[16]
Naghdifar S, Madani M, Ahadi AM. Isolation and identification of inhibitory bacteria against pathogenic fungi from Isfahan using molecular method. J Shahrekord Uuniv Med Sci  2016; 18(5): 83-93.

[17]
Rajaofera M, Jin P, Fan Y, et al. Antifungal activity of the bioactive substance from Bacillus atrophaeus strain HAB-5 and its toxicity assessment on Danio rerio. 2018; 147: 153-61.
 [http://dx.doi.org/10.1016/j.pestbp.2017.06.006]

[18]
Lin HF, Chen TH, Da Liu S. The antifungal mechanism of Bacillus subtilis against Pestalotiopsis eugeniae and its development for commercial applications against wax apple infection. Afr J Microbiol Res  2011; 5(14): 1723-8.

[19]
Routhu SR, Chary RN, Shaik AB, Prabhakar S, Kumar CG, Kamal AJPB. Induction of apoptosis in lung carcinoma cells by antiproliferative cyclic lipopeptides from marine algicolous isolate Bacillus atrophaeus strain AKLSR1. 2019; 79: 142-54.
 [http://dx.doi.org/10.1016/j.procbio.2018.12.010]

[20]
Yang H, Li X, Li X, Yu H, Shen Z. Identification of lipopeptide isoforms by MALDI-TOF-MS/MS based on the simultaneous purification of iturin, fengycin, and surfactin by RP-HPLC. Anal Bioanal Chem  2015; 407(9): 2529-42.
 [http://dx.doi.org/10.1007/s00216-015-8486-8] [PMID: 25662934]

[21]
Nanjundan J, Ramasamy R, Uthandi S, Ponnusamy M. Antimicrobial activity and spectroscopic characterization of surfactin class of lipopeptides from Bacillus amyloliquefaciens SR1. Microb Pathog  2019; 128: 374-80.
 [http://dx.doi.org/10.1016/j.micpath.2019.01.037] [PMID: 30695712]

[22]
Cui T-B, Chai H-Y, Jiang L-X. Isolation and partial characterization of an antifungal protein produced by Bacillus licheniformis BS-3. Molecules  2012; 17(6): 7336-47.
 [http://dx.doi.org/10.3390/molecules17067336] [PMID: 22699567]

[23]
Ebrahimipour GH, Khosravibabadi Z, Sadeghi H, Aliahmadi A. Isolation, partial purification and characterization of an antimicrobial compound, produced by Bacillus atrophaeus. Jundishapur J Microbiol  2014; 7(9): e11802.
 [http://dx.doi.org/10.5812/jjm.11802] [PMID: 25485057]

[24]
Zhao Y, Selvaraj JN, Xing F, et al. Antagonistic action of Bacillus subtilis strain SG6 on Fusarium graminearum. PLoS One  2014; 9(3): e92486.
 [http://dx.doi.org/10.1371/journal.pone.0092486] [PMID: 24651513]

[25]
Pathak KV, Keharia H. Identification of surfactins and iturins produced by potent fungal antagonist, Bacillus subtilis K1 isolated from aerial roots of banyan (Ficus benghalensis) tree using mass spectrometry. 3 Biotech  2014; 4(3): 283-95.

[26]
Lei S, Zhao H, Pang B, et al. Capability of iturin from Bacillus subtilis to inhibit Candida albicans in vitro and in vivo. Appl Microbiol Biotechnol  2019; 103(11): 4377-92.
 [http://dx.doi.org/10.1007/s00253-019-09805-z] [PMID: 30997554]

[27]
Jiang C, Li Z, Shi Y, et al. Bacillus subtilis inhibits Aspergillus carbonarius by producing iturin A, which disturbs the transport, energy metabolism, and osmotic pressure of fungal cells as revealed by transcriptomics analysis. Int J Food Microbiol  2020; 330: 108783.
 [http://dx.doi.org/10.1016/j.ijfoodmicro.2020.108783] [PMID: 32659523]

Rights & Permissions Print Cite

Article Metrics

5

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/1574885517666220601104811	Print ISSN 1574-8855
Publisher Name Bentham Science Publisher	Online ISSN 2212-3903

Current Drug Therapy

Detection of Iturin A from Bacillus atrophaeus by HPLC and Mass Spectrometry Analysis and Evaluation of its Antifungal Activity

Abstract Play Pause

Abstract